Breaking News Instant updates and real-time market news.

2022-05-18 16:18:47 BBWI Bath & Body Works $42.92 / -4.075 (-8.67%) 16:18 05/18/22 05/18 16:18 05/18/22 16:18	Bath & Body Works sees Q2 EPS 60c-65c, consensus 64c The company said, "The company is forecasting second quarter earnings from continuing operations per diluted share between $0.60 and $0.65, compared to $0.77 earnings from continuing operations per diluted share in the prior year."	19 May

2022-05-18 16:18:47

BBWI

Bath & Body Works

$42.92 / -4.075 (-8.67%)

16:18

05/18/22

05/18

16:18

05/18/22

16:18

Bath & Body Works sees Q2 EPS 60c-65c, consensus 64c

The company said, "The company is forecasting second quarter earnings from continuing operations per diluted share between $0.60 and $0.65, compared to $0.77 earnings from continuing operations per diluted share in the prior year."

19
May

OTHER BREAKING NEWS FROM THE FLY

Recommendations	FIS valuation compelling despite margin challenges, says Susquehanna » 06:58 06/27/22 06/27 06:58 06/27/22 06:58 FIS FIS $98.65 / +5.675 (+6.10%) Susquehanna analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FIS FIS $98.65 / +5.675 (+6.10%) 06/07/22 FIS delivers derivatives solution to Societe Generale 05/16/22 Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet 05/11/22 FIS announces new embedded finance offering in partnership with Treasury Prime 02/14/22 FIS announces acquisition of Atlanta-based, Payrix, terms undisclosed FIS FIS $98.65 / +5.675 (+6.10%) 06/13/22 Evercore ISI Evercore upgrades 'compelling' payments incumbent FIS to Outperform 06/13/22 Evercore ISI FIS upgraded to Outperform from In Line at Evercore ISI 05/17/22 Goldman Sachs FIS initiated with a Buy at Goldman Sachs 05/17/22 Mizuho FIS price target lowered to $130 from $135 at Mizuho FIS FIS $98.65 / +5.675 (+6.10%) 05/03/22 FIS sees FY22 EPS $7.25- $7.37, consensus $7.29 05/03/22 FIS l sees Q2 EPS $1.72-$1.75, consensus $1.75 05/03/22 FIS reports Q1 EPS $1.47, consensus $1.45 05/02/22 Notable companies reporting before tomorrow's open FIS FIS $98.65 / +5.675 (+6.10%) 06/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/03/22 Fly Intel: Pre-market Movers 02/15/22 What You Missed On Wall Street On Tuesday 02/15/22 What You Missed On Wall Street This Morning FIS FIS $98.65 / +5.675 (+6.10%) 01/05/22 Fidelity National Information Services call volume above normal and directionally bullish
Hot Stocks	McDonald's names Marion Gross as global chief supply chain officer 06:57 06/27/22 06/27 06:57 06/27/22 06:57 MCD McDonald's $247.85 / +4.24 (+1.74%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MCD McDonald's $247.85 / +4.24 (+1.74%) 06:57 Today McDonald's names Kevin Ozan as SEVP, strategic initiatives, Ian Borden as CFO 06:56 Today McDonald's names Kevin Ozan as SEVP, strategic initiatives, Ian Borden as CFO 06/22/22 McDonald's, Adyen expand mobile app partnership to the U.S. 06/12/22 Fly Intel: Top five weekend stock stories MCD McDonald's $247.85 / +4.24 (+1.74%) 06/22/22 BTIG McDonald's franchisee checks suggest strength, says BTIG 06/09/22 Barclays McDonald's price target lowered to $289 from $300 at Barclays 06/07/22 UBS McDonald's should prove resilient in event of recession, says UBS 05/25/22 Truist McDonald's price target lowered to $273 from $280 at Truist MCD McDonald's $247.85 / +4.24 (+1.74%) 04/28/22 McDonald's reports Q1 adjusted EPS $2.28, consensus $2.17 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open 01/27/22 McDonald's reports Q4 adjusted EPS $2.23, consensus $2.34 MCD McDonald's $247.85 / +4.24 (+1.74%) 06/23/22 McDonald's tightens restaurant ownership rules, WSJ reports 06/16/22 McDonald's to pay $1.3B to settle probes in France, Bloomberg reports 06/12/22 McDonald's in Russia reopens under new ownership, WSJ reports 06/05/22 Icahn drops proxy fight over pig treatment at Kroger, WSJ reports MCD McDonald's $247.85 / +4.24 (+1.74%) 06/16/22 What You Missed On Wall Street This Morning 05/19/22 What You Missed On Wall Street On Thursday 05/19/22 What You Missed On Wall Street This Morning 05/16/22 What You Missed On Wall Street On Monday MCD McDonald's $247.85 / +4.24 (+1.74%) 05/24/22 Early notable gainers among liquid option names on May 24th 04/28/22 Unusually active option classes on open April 28th 04/12/22 Unusually active option classes on open April 12th 04/08/22 Unusually active option classes on open April 8th
Hot Stocks	McDonald's names Kevin Ozan as SEVP, strategic initiatives, Ian Borden as CFO » 06:57 06/27/22 06/27 06:57 06/27/22 06:57 MCD McDonald's $247.85 / +4.24 (+1.74%) McDonald's… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MCD McDonald's $247.85 / +4.24 (+1.74%) 06:56 Today McDonald's names Kevin Ozan as SEVP, strategic initiatives, Ian Borden as CFO 06/22/22 McDonald's, Adyen expand mobile app partnership to the U.S. 06/12/22 Fly Intel: Top five weekend stock stories 06/06/22 Carl Icahn to discontinue proxy contest waged at Kroger, withdraw nominees MCD McDonald's $247.85 / +4.24 (+1.74%) 06/22/22 BTIG McDonald's franchisee checks suggest strength, says BTIG 06/09/22 Barclays McDonald's price target lowered to $289 from $300 at Barclays 06/07/22 UBS McDonald's should prove resilient in event of recession, says UBS 05/25/22 Truist McDonald's price target lowered to $273 from $280 at Truist MCD McDonald's $247.85 / +4.24 (+1.74%) 04/28/22 McDonald's reports Q1 adjusted EPS $2.28, consensus $2.17 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open 01/27/22 McDonald's reports Q4 adjusted EPS $2.23, consensus $2.34 MCD McDonald's $247.85 / +4.24 (+1.74%) 06/23/22 McDonald's tightens restaurant ownership rules, WSJ reports 06/16/22 McDonald's to pay $1.3B to settle probes in France, Bloomberg reports 06/12/22 McDonald's in Russia reopens under new ownership, WSJ reports 06/05/22 Icahn drops proxy fight over pig treatment at Kroger, WSJ reports MCD McDonald's $247.85 / +4.24 (+1.74%) 06/16/22 What You Missed On Wall Street This Morning 05/19/22 What You Missed On Wall Street On Thursday 05/19/22 What You Missed On Wall Street This Morning 05/16/22 What You Missed On Wall Street On Monday MCD McDonald's $247.85 / +4.24 (+1.74%) 05/24/22 Early notable gainers among liquid option names on May 24th 04/28/22 Unusually active option classes on open April 28th 04/12/22 Unusually active option classes on open April 12th 04/08/22 Unusually active option classes on open April 8th
Hot Stocks	AstraZeneca, Merck announce LYNPARZA receives positive opinion from CHMP » 06:57 06/27/22 06/27 06:57 06/27/22 06:57 AZN AstraZeneca $66.90 / +2.43 (+3.77%) , MRK Merck $93.22 / +1.14 (+1.24%) AstraZeneca (AZN) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 06:18 Today AstraZeneca's Lynparza recommended for E.U. approval by CHMP in breast cancer 05:41 Today AstraZeneca, Daiichi Sankyo's Trastuzumab Deruxtecan recommended for approval 06/23/22 AstraZeneca reports detailed results from FoCus Phase 3 trial in Wilson disease 06/22/22 AstraZeneca, Biocartis enter agreement on companion diagnostic test for Tagrisso MRK Merck $93.22 / +1.14 (+1.24%) 06:18 Today AstraZeneca's Lynparza recommended for E.U. approval by CHMP in breast cancer 06/24/22 European Commission approves KEYTRUDA as adjuvant treatment for melanoma 06/24/22 Merck: EC approves KEYTRUDA for treatment of stage IIB or IIC melanoma 06/22/22 Merck says CDC panel votes to provisionally recommend use of Vaxneuvance AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 06/14/22 UBS AstraZeneca downgraded to Neutral from Buy at UBS 05/24/22 Danske Bank AstraZeneca initiated with a Buy at Danske Bank 05/18/22 Kepler Cheuvreux AstraZeneca downgraded to Hold from Buy at Kepler Cheuvreux 04/21/22 Morgan Stanley AstraZeneca price target raised to 11,100 GBp from 10,200 GBp at Morgan Stanley MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 Mizuho Merck deal would add 'novel and validated technology,' says Mizuho 06/21/22 Oppenheimer Seagen price target raised to $208 from $160 at Oppenheimer 04/12/22 Barclays Merck price target raised to $97 from $94 at Barclays 04/11/22 H.C. Wainwright Rubius Therapeutics price target lowered to $15 from $40 at H.C. Wainwright AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 04/29/22 AstraZeneca backs FY22 core EPS up by mid to high twenties percentage 04/29/22 AstraZeneca reports Q1 core EPS $1.89, up 20% y/y 02/10/22 AstraZeneca sees FY22 core EPS up by mid to high twenties percentage 02/10/22 AstraZeneca reports Q4 core EPS $1.67, two estimates 73c MRK Merck $93.22 / +1.14 (+1.24%) 04/28/22 Merck raises FY22 adjusted EPS view to $7.24-$7.36, consensus $7.24 04/28/22 Merck reports Q1 adjusted EPS $2.14, consensus $1.83 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 06/17/22 AstraZeneca considering bid for Mereo BioPharma, U.K. Times reports 05/10/22 Emergent plant's quality problems led to 400M discarded vaccines, WSJ reports 03/23/22 AstraZeneca preventive COVID shot set to win EU clearance, Reuters says MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 Merck moving forward with potential Seagen deal, WSJ reports 06/17/22 Merck, other suitors interested in acquiring Seagen, WSJ reports 06/17/22 Merck considering acquisition of Seagen, WSJ reports 05/31/22 Pfizer's Paxlovid becomes leading pandemic pill, WSJ reports AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 05/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/06/22 Fly Intel: Pre-market Movers 03/23/22 What You Missed On Wall Street On Wednesday 03/23/22 What You Missed On Wall Street This Morning MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Fly Intel: Pre-market Movers 06/17/22 What You Missed On Wall Street On Friday 07/28/22 Merck - MRK 07/01/22 Extended PDUFA Date for Vaxneuvance 01/29/23 PDUFA Date for new sBLA for KEYTRUDA 10/04/22 Merck AZN MRK AZN AstraZeneca $66.90 / +2.43 (+3.77%) 06/06/22 Unusually active option classes on open June 6th 04/26/22 AstraZeneca call volume above normal and directionally bullish 04/07/22 AstraZeneca put volume heavy and directionally bearish 03/03/22 AstraZeneca put volume heavy and directionally bearish MRK Merck $93.22 / +1.14 (+1.24%) 06/01/22 Merck put volume heavy and directionally bearish 05/31/22 Merck put volume heavy and directionally bearish 05/18/22 Merck put volume heavy and directionally bearish 04/04/22 Merck call buyer realizes 64% same-day gains
Upgrade	Simply Good Foods upgraded to Overweight from Equal Weight at Stephens » 06:56 06/27/22 06/27 06:56 06/27/22 06:56 SMPL Simply Good Foods $38.81 / +0.45 (+1.17%) Stephens analyst Ben… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SMPL Simply Good Foods $38.81 / +0.45 (+1.17%) 04/13/22 Simply Good Foods announces $50M addition to share repurchase program SMPL Simply Good Foods $38.81 / +0.45 (+1.17%) 05/19/22 Mizuho Mizuho recommends buying three food stocks on recent selloff 04/07/22 Goldman Sachs Simply Good Foods price target raised to $50 from $45 at Goldman Sachs 04/07/22 Stephens Simply Good Foods price target raised to $44 from $41 at Stephens 04/07/22 Deutsche Bank Simply Good Foods price target raised to $48 from $45 at Deutsche Bank SMPL Simply Good Foods $38.81 / +0.45 (+1.17%) 04/06/22 Simply Good Foods raises 2022 net sales view up 13%-15% from up 12%-14% 04/06/22 Simply Good Foods reports Q2 adjusted EPS 36c, consensus 27c 01/05/22 Simply Good Foods expects 2022 net sales to increase 12%-14% vs. 2021 01/05/22 Simply Good Foods reports Q1 adjusted EPS 43c, consensus 34c SMPL Simply Good Foods $38.81 / +0.45 (+1.17%) 04/06/22 What You Missed On Wall Street On Wednesday 04/06/22 What You Missed On Wall Street This Morning 04/06/22 Fly Intel: Pre-market Movers 03/30/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/30/22 Simply Good Foods - SMPL

Hot Stocks	McDonald's names Kevin Ozan as SEVP, strategic initiatives, Ian Borden as CFO 06:56 06/27/22 06/27 06:56 06/27/22 06:56 MCD McDonald's $247.85 / +4.24 (+1.74%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MCD McDonald's $247.85 / +4.24 (+1.74%) 06/22/22 McDonald's, Adyen expand mobile app partnership to the U.S. 06/12/22 Fly Intel: Top five weekend stock stories 06/06/22 Carl Icahn to discontinue proxy contest waged at Kroger, withdraw nominees 05/26/22 McDonald's shareholders re-elect all 12 directors at annual meeting MCD McDonald's $247.85 / +4.24 (+1.74%) 06/22/22 BTIG McDonald's franchisee checks suggest strength, says BTIG 06/09/22 Barclays McDonald's price target lowered to $289 from $300 at Barclays 06/07/22 UBS McDonald's should prove resilient in event of recession, says UBS 05/25/22 Truist McDonald's price target lowered to $273 from $280 at Truist MCD McDonald's $247.85 / +4.24 (+1.74%) 04/28/22 McDonald's reports Q1 adjusted EPS $2.28, consensus $2.17 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open 01/27/22 McDonald's reports Q4 adjusted EPS $2.23, consensus $2.34 MCD McDonald's $247.85 / +4.24 (+1.74%) 06/23/22 McDonald's tightens restaurant ownership rules, WSJ reports 06/16/22 McDonald's to pay $1.3B to settle probes in France, Bloomberg reports 06/12/22 McDonald's in Russia reopens under new ownership, WSJ reports 06/05/22 Icahn drops proxy fight over pig treatment at Kroger, WSJ reports MCD McDonald's $247.85 / +4.24 (+1.74%) 06/16/22 What You Missed On Wall Street This Morning 05/19/22 What You Missed On Wall Street On Thursday 05/19/22 What You Missed On Wall Street This Morning 05/16/22 What You Missed On Wall Street On Monday MCD McDonald's $247.85 / +4.24 (+1.74%) 05/24/22 Early notable gainers among liquid option names on May 24th 04/28/22 Unusually active option classes on open April 28th 04/12/22 Unusually active option classes on open April 12th 04/08/22 Unusually active option classes on open April 8th
Hot Stocks	Sitio Royalties announces it completes acquisitions of 31,900 NRAs » 06:55 06/27/22 06/27 06:55 06/27/22 06:55 STR Sitio Royalties $23.13 / +0.62 (+2.75%) Sitio Royalties announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options STR Sitio Royalties $23.13 / +0.62 (+2.75%) 06/07/22 Desert Peak Minerals, Falcon Minerals complete merger, creating Sitio Royalties STR Sitio Royalties $23.13 / +0.62 (+2.75%) 06/15/22 Credit Suisse Credit Suisse upgrades Sitio to Outperform, names new Top Pick in royalties 06/15/22 Credit Suisse Sitio Royalties upgraded to Outperform from Neutral at Credit Suisse STR Sitio Royalties $23.13 / +0.62 (+2.75%) 06/06/22 Two new option listings and two option delistings on June 6th
Recommendations	CarMax valuation attractive for patient investors, says Baird » 06:54 06/27/22 06/27 06:54 06/27/22 06:54 KMX CarMax $98.44 / +6.68 (+7.28%) Baird analyst Craig… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 CarMax plans to open ten new locations in FY23 06/24/22 CarMax sold 427,257 units in Q1, down 5.5% from the prior year quarter 05/16/22 Tepper's Appaloosa buys two casinos in Q1, exits T-Mobile and GM 04/12/22 CarMax drops 5% to $98.05 after Q4 earnings miss estimates KMX CarMax $98.44 / +6.68 (+7.28%) 06/07/22 JPMorgan CarMax price target lowered to $105 from $110 at JPMorgan 05/16/22 Evercore ISI CarMax added to 'Tactical Outperform' list at Evercore ISI 05/02/22 Needham Needham starts CarMax at Hold amid increased spending on omni-channel strategy 05/02/22 Needham CarMax initiated with a Hold at Needham KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 CarMax reports Q1 EPS $1.56, consensus $1.49 06/23/22 Notable companies reporting before tomorrow's open 06/23/22 Notable companies reporting before tomorrow's open 04/12/22 CarMax reports Q4 EPS 98c, consensus $1.25 KMX CarMax $98.44 / +6.68 (+7.28%) 02/26/22 Deere among quality companies doing business mostly in the U.S., Barron's says KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 05/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/13/22 What You Missed On Wall Street On Wednesday 09/29/22 CarMax - KMX 06/28/22 CarMax Inc. KMX CarMax $98.44 / +6.68 (+7.28%) 04/12/22 Unusually active option classes on open April 12th
Recommendations	Stifel still sees value in Carnival despite 'drastically' cutting estimates » 06:52 06/27/22 06/27 06:52 06/27/22 06:52 CCL Carnival $10.87 / +1.22 (+12.65%) Stifel analyst Steven… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Carnival Cruise Line brand to reach nearly 110% occupancy in Q3, says CEO 06/24/22 Carnival CEO says 'aggressively, yet thoughtfully ramping up to full operations' 06/24/22 Carnival reports Q2 occupancy 69%, up from 54% in Q1 06/24/22 Carnival provides update on bookings CCL Carnival $10.87 / +1.22 (+12.65%) 06:47 Today Wells Fargo Carnival price target lowered to $13 from $21 at Wells Fargo 06/21/22 Deutsche Bank Carnival price target lowered to $14 from $24 at Deutsche Bank 06/14/22 HSBC Carnival price target lowered to $7.70 from $18.20 at HSBC 06/09/22 Susquehanna Carnival initiated with a Neutral at Susquehanna CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Carnival expects a net loss for Q3 06/24/22 Carnival reports Q2 EPS ($1.61), consensus ($1.08) 06/23/22 Notable companies reporting before tomorrow's open 06/23/22 Notable companies reporting before tomorrow's open CCL Carnival $10.87 / +1.22 (+12.65%) 06/13/22 Carnival CEO tells Bloomberg company is 'recession resilient' 05/24/22 Carnival in talks to sell Seabourn to Saudi fund, CNBC's Mody reports 03/02/22 Carnival, Norwegian update mask policy, now optional for most, WSJ reports 01/07/22 Royal Caribbean, Norwegian Cruise cancel trips due to omicron, Reuters reports CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/17/22 Bet On It: Maryland governor calls for online sports betting timeline 05/24/22 What You Missed On Wall Street On Tuesday CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Early notable gainers among liquid option names on June 24th 05/26/22 Notable open interest changes for May 26th 05/25/22 Unusually active option classes on open May 25th 05/25/22 Notable open interest changes for May 25th
Hot Stocks	Bright Minds Biosciences names Jan Torleif Pedersen as interim CSO » 06:52 06/27/22 06/27 06:52 06/27/22 06:52 DRUG Bright Minds Biosciences / + Bright Minds Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News DRUG Bright Minds Biosciences / + 03/14/22 Bright Minds Biosciences says no major toxicological findings from BMB-101 study

Downgrade	Alnylam downgraded to Neutral from Buy at Guggenheim » 06:51 06/27/22 06/27 06:51 06/27/22 06:51 ALNY Alnylam $147.57 / +1.375 (+0.94%) Guggenheim analyst Debjit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ALNY Alnylam $147.57 / +1.375 (+0.94%) 06/13/22 Alnylam announces FDA approval of AMVUTTRA 06/09/22 Alnylam Regeneron reports results from Phase 2 study of cemdisiran 06/02/22 Alnylam: C16-siRNA led to potent, durable knockdown in CNS, behavioral deficits 06/01/22 ProQR Therapeutics provides leadership updates ALNY Alnylam $147.57 / +1.375 (+0.94%) 06:30 Today Guggenheim Alnylam downgraded to Neutral from Buy at Guggenheim 06/21/22 Piper Sandler Ionis told Piper eplontersen efficacy competitive with Amvuttra 06/15/22 Citi Citi opens positive '90-day Catalyst Watch' Alnylam after approval 06/14/22 Piper Sandler Piper bullish on Alnylam as FDA approves AMVUTTRA for hATTR Polyneuropathy ALNY Alnylam $147.57 / +1.375 (+0.94%) 04/28/22 Alnylam reports Q1 EPS ($2.00), consensus ($1.84) 02/10/22 Alnylam reports Q4 EPS ($1.69), consensus ($1.54) 02/10/22 Alnylam reports Q4 EPS ($1.69), consensus ($1.54) 01/09/22 Alnylam sees preliminary FY21 combined product revenues $662M ALNY Alnylam $147.57 / +1.375 (+0.94%) 06/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/17/22 What You Missed On Wall Street On Thursday 03/17/22 What You Missed On Wall Street This Morning 01/21/22 Fly Intel: Pre-market Movers 07/14/22 Extended PDUFA Date for Vutrisiran 10/06/22 PDUFA Date for Oxlumo (Lumasiran)
Initiation	Deckers Brands resumed with an Equal Weight at Wells Fargo » 06:51 06/27/22 06/27 06:51 06/27/22 06:51 DECK Deckers Brands $273.32 / +11.79 (+4.51%) Wells Fargo analyst Kate… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DECK Deckers Brands $273.32 / +11.79 (+4.51%) 06/10/22 Deckers Brands COO David Lafitte to step down 06/10/22 Deckers Brands names Angela Ogbechie as Chief Supply Chain Officer 06/09/22 Sanuk, Grateful Dead announce sixth iteration of ongoing collaboration 05/20/22 Deckers Brands rises 11.7% DECK Deckers Brands $273.32 / +11.79 (+4.51%) 05/20/22 BTIG Demand for Deckers brands UGG/HOKA 'not skipping a beat', says BTIG 05/20/22 Cowen Deckers Brands price target raised to $407 from $358 at Cowen 05/20/22 Stifel Deckers Brands price target raised to $338 from $315 at Stifel 05/20/22 Baird Deckers Brands price target lowered to $375 from $525 at Baird DECK Deckers Brands $273.32 / +11.79 (+4.51%) 05/19/22 Deckers Brands sees FY23 EPS $17.40-$18.25, consensus $18.34 05/19/22 Deckers Brands reports Q4 EPS $2.51, consensus $1.32 05/19/22 Notable companies reporting after market close 02/03/22 Deckers Brands reports Q3 EPS $8.42, consensus $8.19 DECK Deckers Brands $273.32 / +11.79 (+4.51%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 05/19/22 Fly Intel: After-Hours Movers
Hot Stocks	Genesco appoints Gregory Sandfort as lead independent director » 06:51 06/27/22 06/27 06:51 06/27/22 06:51 GCO Genesco $56.64 / +2.46 (+4.54%) Genesco Inc. announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GCO Genesco $56.64 / +2.46 (+4.54%) 03/10/22 Genesco rises 11.4% 01/10/22 Genesco reports Q4 QTD sales up 18% GCO Genesco $56.64 / +2.46 (+4.54%) 03/10/22 CL King Genesco's competitive moat more evident than ever, says CL King 01/18/22 Seaport Global Seaport lists Nike, Foot Locker among Buys in Apparel/Footwear sector 01/18/22 Seaport Global Genesco initiated with a Buy at Seaport Global 11/30/21 Jefferies Genesco assumed with a Hold at Jefferies GCO Genesco $56.64 / +2.46 (+4.54%) 05/26/22 Genesco backs FY23 adjusted EPS $7.00-$7.75, consensus $7.41 05/26/22 Genesco reports Q1 adjusted EPS 44c, consensus (9c) 03/10/22 Genesco sees FY23 adjusted EPS $7.00-$7.75, consensus $7.13 03/10/22 Genesco reports Q4 EPS $3.48, consensus $2.64
Recommendations	Bed Bath & Beyond price target lowered to $7 from $14 at Baird » 06:50 06/27/22 06/27 06:50 06/27/22 06:50 BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) Baird analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 06/23/22 Bed Bath & Beyond launches new savings program, Welcome Rewards 05/12/22 GameStop, AMC, Bed Bath & Beyond rise as 'meme stocks' see momentum 04/22/22 Bed Bath & Beyond trading resumes 04/22/22 Bed Bath & Beyond up 11% after WSJ report on buyout interest for baby unit BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 06/22/22 BofA BofA cuts Bed Bath & Beyond target to $3, says buybuy BABY sale unlikely 06/22/22 Wedbush Bed Bath & Beyond price target lowered to $7 from $14 at Wedbush 06/22/22 UBS Bed Bath & Beyond price target lowered to $5 from $12 at UBS 05/17/22 B. Riley Bed Bath & Beyond price target lowered to $17 from $26 at B. Riley BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 04/13/22 Bed Bath & Beyond reports Q4 adjusted EPS (92c), consensus 3c 04/12/22 Notable companies reporting before tomorrow's open 04/12/22 Notable companies reporting before tomorrow's open 01/06/22 Bed Bath & Beyond cuts FY21 adjusted EPS view to (15c)-0c from 70c-$1.10 BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 04/22/22 Bed Bath & Beyond seeing interest from suitors for Buybuy Baby, WSJ says 04/22/22 Bed Bath & Beyond's Buybuy Baby seeing interest from suitors, WSJ says 03/25/22 Bed Bath near settlement with Cohen, to add three directors, Bloomberg reports 03/06/22 Chewy co-founder Ryan Cohen takes large stake in Bed Bath & Beyond, WSJ says BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 04/22/22 What You Missed On Wall Street On Friday 04/14/22 What You Missed On Wall Street On Thursday 04/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/13/22 What You Missed On Wall Street On Wednesday 06/29/22 Bed Bath & Beyond - BBBY 07/14/22 Bed Bath & Beyond Inc. BBBY Bed Bath & Beyond $6.99 / -0.145 (-2.03%) 06/23/22 Bed Bath & Beyond call volume above normal and directionally bullish 06/21/22 Bed Bath & Beyond call volume above normal and directionally bullish 06/17/22 Bed Bath & Beyond call volume above normal and directionally bullish 06/02/22 Bed Bath & Beyond call volume above normal and directionally bullish
Hot Stocks	TCR2 Therapeutics names Eric Sullivan as CFO » 06:49 06/27/22 06/27 06:49 06/27/22 06:49 TCRR TCR2 Therapeutics $2.87 / +0.06 (+2.14%) TCR2 Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TCRR TCR2 Therapeutics $2.87 / +0.06 (+2.14%) 01/12/22 TCR2 Therapeutics names Rosemary Harrison as Chief Business and Strategy Officer 01/04/22 TCR2 Therapeutics, Arbor establish collaboration for TRuc-T cell therapies TCRR TCR2 Therapeutics $2.87 / +0.06 (+2.14%) 05/19/22 H.C. Wainwright TCR2 Therapeutics price target lowered to $14 from $19 at H.C. Wainwright 05/12/22 Piper Sandler TCR2 Therapeutics price target lowered to $15 from $23 at Piper Sandler 03/22/22 Piper Sandler TCR2 Therapeutics price target lowered to $23 from $26 at Piper Sandler 01/19/22 Goldman Sachs TCR2 Therapeutics assumed with Neutral from Buy at Goldman Sachs TCRR TCR2 Therapeutics $2.87 / +0.06 (+2.14%) 05/12/22 TCR2 Therapeutics reports Q1 EPS (76c), consensus (74c) 03/22/22 TCR2 Therapeutics reports Q4 EPS (72c), consensus (75c) 00:00 Today Truist Securities Cell Therapy Symposium: Symposia-cel

Recommendations	Celanese price target lowered to $180 from $200 at Wells Fargo » 06:49 06/27/22 06/27 06:49 06/27/22 06:49 CE Celanese $127.55 / +7.18 (+5.96%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CE Celanese $127.55 / +7.18 (+5.96%) 05/25/22 Celanese announces acetyl intermediate price increases 05/16/22 Berkshire Hathaway adds Citi, exits Wells Fargo in Q1 05/11/22 Celanese declares Force Majeure on acetyl chain and acetate two products 03/31/22 Celanese sees EPS accretion from KEP restructuring 15-20c over three years CE Celanese $127.55 / +7.18 (+5.96%) 06:16 Today Credit Suisse Celanese initiated with an Underperform at Credit Suisse 06/16/22 Jefferies Celanese downgraded to Hold from Buy at Jefferies 05/18/22 Piper Sandler Celanese price target raised to $145 from $140 at Piper Sandler 04/13/22 Fermium Research DuPont price target lowered to $78 from $87 at Fermium Research CE Celanese $127.55 / +7.18 (+5.96%) 04/28/22 Celanese sees FY22 adjusted EPS approaching FY21 adjusted EPS 04/28/22 Celanese reports Q1 adjusted EPS $5.54, consensus $4.52 01/27/22 Celanese sees FY22 EPS 'at least' $15.00, consensus $15.85 01/27/22 Celanese sees Q1 EPS $4.30-$4.60, consensus $4.19 CE Celanese $127.55 / +7.18 (+5.96%) 02/17/22 Celanese near deal to buy DuPont materials unit for over $10B, Bloomberg says 02/17/22 Celanese near deal to buy DuPont materials unit for over $10B, Bloomberg says CE Celanese $127.55 / +7.18 (+5.96%) 06/16/22 What You Missed On Wall Street On Thursday 06/16/22 What You Missed On Wall Street This Morning 06/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/22 What You Missed On Wall Street On Tuesday CE Celanese $127.55 / +7.18 (+5.96%) 05/17/22 Early notable gainers among liquid option names on May 17th 04/29/22 Early notable gainers among liquid option names on April 29th
Hot Stocks	BWX executes commercial agreement with Bayer for supply of Actinium-225 » 06:47 06/27/22 06/27 06:47 06/27/22 06:47 BWXT BWX Technologies $53.17 / +2.635 (+5.21%) , BAYRY Bayer $15.23 / -0.15 (-0.98%) BWX Technologies (BWXT)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BWXT BAYRY BWXT BWX Technologies $53.17 / +2.635 (+5.21%) 06/13/22 BWX Medical, TRIUMF execute licensing and services agreement 06/09/22 BWX Technologies to build first advanced nuclear microreactor in U.S. 05/03/22 BWX Technologies names Jan Bertsch chair of the board 05/03/22 BWX Technologies names Jan Bertsch chair of the board BAYRY Bayer $15.23 / -0.15 (-0.98%) 05/24/22 Senti Bio secures additional financing from Leaps by Bayer 05/19/22 Atara provides update on Bayer collaboration 05/10/22 Bayer confirms outlook for 2022 05/04/22 Bayer reports FDA accepts sNDA and grants priority review for Nubeqa combo BWXT BAYRY BWXT BWX Technologies $53.17 / +2.635 (+5.21%) 03/16/22 BofA BWX Technologies price target raised to $65 from $55 at BofA 12/14/21 Maxim BWX Technologies price target lowered to $65 from $68 at Maxim 11/17/21 Maxim BWX Technologies price target lowered to $68 from $77 at Maxim 11/02/21 Truist BWX Technologies price target lowered to $70 from $77 at Truist BAYRY Bayer $15.23 / -0.15 (-0.98%) 06/13/22 Redburn FMC downgraded to Neutral on cost inflation at Redburn 05/19/22 UBS Bayer price target raised to EUR 96 from EUR 90 at UBS 05/11/22 Barclays Bayer price target raised to EUR 90 from EUR 85 at Barclays 05/11/22 Credit Suisse Bayer price target raised to EUR 62 from EUR 56 at Credit Suisse BWXT BAYRY BWXT BWX Technologies $53.17 / +2.635 (+5.21%) 05/09/22 BWX Technologies backs FY22 adjusted EPS $3.05-$3.25, consensus $3.14 05/09/22 BWX Technologies reports Q1 adjusted EPS 69c, consensus 67c 02/22/22 BWX Technologies sees FY22 adjusted EPS $3.05-$3.25, consensus $3.12 02/22/22 BWX Technologies reports Q4 adjusted EPS 95c, consensus 93c BAYRY Bayer $15.23 / -0.15 (-0.98%) 05/10/22 Bayer reports Q1 core EPS EUR 3.53 vs. EUR 2.59 last year 03/01/22 Bayer sees 2022 group sales of EUR 47B 03/01/22 Bayer reports Q4 core EPS EUR 1.26 vs. EUR 1.32 last year BAYRY BAYRY Bayer $15.23 / -0.15 (-0.98%) 06/21/22 Supreme Court rejects Bayer bid to end Roundup suits, Bloomberg reports 05/11/22 Biden administration asks Supreme Court to reject Roundup appeal, Reuters says BAYRY BAYRY Bayer $15.23 / -0.15 (-0.98%) 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 05/11/22 What You Missed On Wall Street On Wednesday 05/11/22 What You Missed On Wall Street This Morning
Recommendations	Carnival price target lowered to $13 from $21 at Wells Fargo » 06:47 06/27/22 06/27 06:47 06/27/22 06:47 CCL Carnival $10.87 / +1.22 (+12.65%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Carnival Cruise Line brand to reach nearly 110% occupancy in Q3, says CEO 06/24/22 Carnival CEO says 'aggressively, yet thoughtfully ramping up to full operations' 06/24/22 Carnival reports Q2 occupancy 69%, up from 54% in Q1 06/24/22 Carnival provides update on bookings CCL Carnival $10.87 / +1.22 (+12.65%) 06/21/22 Deutsche Bank Carnival price target lowered to $14 from $24 at Deutsche Bank 06/14/22 HSBC Carnival price target lowered to $7.70 from $18.20 at HSBC 06/09/22 Susquehanna Carnival initiated with a Neutral at Susquehanna 06/08/22 Morgan Stanley Carnival price target lowered to $13 from $17 at Morgan Stanley CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Carnival expects a net loss for Q3 06/24/22 Carnival reports Q2 EPS ($1.61), consensus ($1.08) 06/23/22 Notable companies reporting before tomorrow's open 06/23/22 Notable companies reporting before tomorrow's open CCL Carnival $10.87 / +1.22 (+12.65%) 06/13/22 Carnival CEO tells Bloomberg company is 'recession resilient' 05/24/22 Carnival in talks to sell Seabourn to Saudi fund, CNBC's Mody reports 03/02/22 Carnival, Norwegian update mask policy, now optional for most, WSJ reports 01/07/22 Royal Caribbean, Norwegian Cruise cancel trips due to omicron, Reuters reports CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/17/22 Bet On It: Maryland governor calls for online sports betting timeline 05/24/22 What You Missed On Wall Street On Tuesday CCL Carnival $10.87 / +1.22 (+12.65%) 06/24/22 Early notable gainers among liquid option names on June 24th 05/26/22 Notable open interest changes for May 26th 05/25/22 Unusually active option classes on open May 25th 05/25/22 Notable open interest changes for May 25th
Initiation	Blueprint Medicines initiated with an Underweight at Wells Fargo » 06:47 06/27/22 06/27 06:47 06/27/22 06:47 BPMC Blueprint Medicines $60.12 / +3.75 (+6.65%) Wells Fargo analyst Derek… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly BPMC Blueprint Medicines $60.12 / +3.75 (+6.65%) 06/09/22 Blueprint Medicines provides updates on AYVAKIT/AYVAKYT program in SM 05/02/22 Roivant Sciences announces collaborations in targeted protein degradation 04/08/22 Blueprint Medicines says SYMPHONY results support development expansion 03/25/22 Blueprint Medicines' AYVAKYT receives EC approval for expanded indication BPMC Blueprint Medicines $60.12 / +3.75 (+6.65%) 06/14/22 Morgan Stanley Blueprint Medicines price target lowered to $65 from $92 at Morgan Stanley 06/09/22 Citi Citi downgrades Blueprint to Sell on Ayvakit market concerns 06/09/22 Citi Blueprint Medicines downgraded to Sell from Neutral at Citi 06/03/22 Wedbush Wedbush downgrades Turning Point, says deal positive for small/mid-cap biotechs BPMC Blueprint Medicines $60.12 / +3.75 (+6.65%) 05/03/22 Blueprint Medicines sees FY22 revenue $180M-$200M, consensus $192.34M 05/03/22 Blueprint Medicines reports Q1 EPS ($1.79), consensus ($1.86) 02/16/22 Blueprint Medicines sees 2022 revenue $180M-$200M, consensus $210.91M 02/16/22 Blueprint Medicines reports Q4 EPS ($5.40), consensus ($1.65) BPMC Blueprint Medicines $60.12 / +3.75 (+6.65%) 06/09/22 What You Missed On Wall Street On Thursday 06/09/22 What You Missed On Wall Street This Morning 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning
Initiation	Eve Holding initiated with a Neutral at BTIG » 06:46 06/27/22 06/27 06:46 06/27/22 06:46 EVEX Eve Holding $6.31 / +0.135 (+2.19%) BTIG analyst Marvin Fong… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly EVEX Eve Holding $6.31 / +0.135 (+2.19%) 06/10/22 Eve Holding rises 7.4% 06/07/22 Eve Holding rises 17.3% 05/31/22 Eve Holding partners with Porsche consulting on eVTOL strategy 05/20/22 Eve Holding Inc trading resumes EVEX Eve Holding $6.31 / +0.135 (+2.19%) 05/19/22 Fly Intel: After-Hours Movers

Downgrade	Cracker Barrel downgraded to Underperform from Neutral at BofA » 06:46 06/27/22 06/27 06:46 06/27/22 06:46 CBRL Cracker Barrel $89.74 / +3.73 (+4.34%) BofA analyst Sara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CBRL Cracker Barrel $89.74 / +3.73 (+4.34%) 06/07/22 Cracker Barrel drops 5% to $96.50 after Q3 results miss estimates 06/07/22 Cracker Barrel CEO cites 'high inflationary pressures' in Q3 06/07/22 Cracker Barrel announces new $200M share repurchase program 06/06/22 Biglari Capital issues letter to shareholders of Cracker Barrel CBRL Cracker Barrel $89.74 / +3.73 (+4.34%) 06:05 Today BofA Cracker Barrel downgraded to Underperform from Neutral at BofA 06/23/22 Truist Cracker Barrel price target lowered to $94 from $104 at Truist 06/09/22 Deutsche Bank Cracker Barrel price target lowered to $109 from $140 at Deutsche Bank 06/08/22 MKM Partners Cracker Barrel price target lowered to $110 from $115 at MKM Partners CBRL Cracker Barrel $89.74 / +3.73 (+4.34%) 06/07/22 Cracker Barrel sees Q4 revenue up 8% y/y, consensus $854.84M 06/07/22 Cracker Barrel reports Q3 adjusted EPS $1.29, consensus $1.31 02/22/22 Cracker Barrel sees Q2 revenue $800M, consensus $788.07M 02/22/22 Cracker Barrel reports Q2 EPS $1.71, consensus $1.61 CBRL Cracker Barrel $89.74 / +3.73 (+4.34%) 02/22/22 What You Missed On Wall Street On Tuesday 02/22/22 What You Missed On Wall Street This Morning
General news	U.S. durable goods preview » 06:45 06/27/22 06/27 06:45 06/27/22 06:45 $ECON Economic Data / + U.S. durable goods… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports 03/09/22 U.S. funding bill hits snag over COVID-relief money, WSJ reports $ECON Economic Data / + 06/15/22 What You Missed On Wall Street On Wednesday 05/12/22 What You Missed On Wall Street On Thursday 05/04/22 What You Missed On Wall Street On Wednesday 04/20/22 What You Missed On Wall Street On Wednesday
General news	U.S. pending home sales preview » 06:45 06/27/22 06/27 06:45 06/27/22 06:45 $ECON Economic Data / + U.S. pending home sales… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports 03/09/22 U.S. funding bill hits snag over COVID-relief money, WSJ reports $ECON Economic Data / + 06/15/22 What You Missed On Wall Street On Wednesday 05/12/22 What You Missed On Wall Street On Thursday 05/04/22 What You Missed On Wall Street On Wednesday 04/20/22 What You Missed On Wall Street On Wednesday
Hot Stocks	Otis Worldwide appoints Anurag Maheshwari EVP, CFO » 06:42 06/27/22 06/27 06:42 06/27/22 06:42 OTIS Otis Worldwide $70.83 / +2.25 (+3.28%) Otis Worldwide… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly OTIS Otis Worldwide $70.83 / +2.25 (+3.28%) 04/22/22 Otis Worldwide raises quarterly dividend 20.8% to 29c per share 04/08/22 Otis Worldwide receives results of Zardoya tender offer 02/15/22 Otis Worldwide announces medium-term outlook at investor day OTIS Otis Worldwide $70.83 / +2.25 (+3.28%) 06/22/22 Berenberg Otis Worldwide price target lowered to $80 from $88 at Berenberg 05/24/22 Barclays Otis Worldwide upgraded to Overweight from Equal Weight at Barclays 04/26/22 Cowen Otis Worldwide price target lowered to $85 from $91 at Cowen 04/26/22 Barclays Otis Worldwide price target lowered to $80 from $88 at Barclays OTIS Otis Worldwide $70.83 / +2.25 (+3.28%) 04/25/22 Otis Worldwide raises FY22 adjusted EPS view to $3.22-$3.27 from up 6%-10% 04/25/22 Otis Worldwide reports Q1 adjusted EPS 77c, consensus 74c 02/15/22 Otis Worldwide backs FY22 EPS view up 6%-10%, consensus $3.28 01/31/22 Otis Worldwide sees FY22 adjusted EPS $3.20-$3.30, consensus $3.29 OTIS Otis Worldwide $70.83 / +2.25 (+3.28%) 03/22/22 Toshiba's elevator unit draws interest from Midea, Otis, Bloomberg says 03/22/22 Toshiba's elevator unit draws interest from Midea, Otis, Bloomberg says OTIS Otis Worldwide $70.83 / +2.25 (+3.28%) 05/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/25/22 What You Missed On Wall Street On Monday 04/25/22 What You Missed On Wall Street This Morning 03/22/22 What You Missed On Wall Street On Tuesday
Initiation	Darden reinstated with a Buy at BofA » 06:41 06/27/22 06/27 06:41 06/27/22 06:41 DRI Darden $119.79 / +4.17 (+3.61%) BofA analyst Katherine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DRI Darden $119.79 / +4.17 (+3.61%) 06/23/22 Darden announces new $1B share repurchase program 06/23/22 Darden reports Q4 blended same-restaurant sales up 11.7% 06/23/22 Darden raises quarterly dividend 10% to $1.21 per share 03/24/22 Darden reports Q3 blended same-restaurant sales up 38.1% DRI Darden $119.79 / +4.17 (+3.61%) 06:38 Today BofA Correction: Darden reinstated with a Buy at BofA 06/24/22 BMO Capital Darden price target lowered to $130 from $140 at BMO Capital 06/24/22 RBC Capital Darden price target lowered to $143 from $151 at RBC Capital 06/24/22 Morgan Stanley Darden price target lowered to $148 from $161 at Morgan Stanley DRI Darden $119.79 / +4.17 (+3.61%) 06/23/22 Darden sees FY23 diluted cont ops EPS $7.40-$8.00, consensus $8.15 06/23/22 Darden reports Q4 EPS $2.24, consensus $2.21 06/22/22 Notable companies reporting before tomorrow's open 06/22/22 Notable companies reporting before tomorrow's open DRI Darden $119.79 / +4.17 (+3.61%) 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 06/23/22 Fly Intel: Pre-market Movers 04/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Events

Earnings calls, analyst events, roadshows and more

RLAY
Today at 08:00

Relay Therapeutics Firm Sponsored Meetings

Virtual Meeting
THO
Today at 09:00

Thor Industries Firm Sponsored Meetings

Airstream Headquarters, Jackson Center, OH
Today at 09:00

Technology/EV Supply Chain Industry Meetings
QRTEA
Today at 09:30

Qurate Retail Firm Sponsored Meetings

Virtual Meeting
NPSNY
Today at 10:00

Naspers - NPSNY Conference Calls
Today at 10:00

Consumer Industry Meetings
UTHR
Today at 10:30

United Therapeutics Corporation Firm Sponsored Meetings
DELL
Today at 10:30

Dell Technologies Inc. CL C Firm Sponsored Meetings
ORGN
Today at 11:00

Origin Materials Inc. Firm Sponsored Meetings
NTAP
Today at 11:30

NetApp - NTAP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	IE X IE Ivanhoe Electric IPO Managers: BMO Capital & Jefferies, JPMorgan, Raymond James, RBC Capital, Scotiabank $11.75-12.50 14.388M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUYA X TUYA Tuya Secondary Managers: CICC, BofA, Morgan Stanley & CMBI $2.30 7.3M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Bath & Body Works sees Q2 EPS 60c-65c, consensus 64c

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access